Stoll-Keller F - Search Results

1

Lepiller Q, Fafi-Kremer S, Stoll-Keller F, Herbein G. Lepiller Q, et al. Virologie (Montrouge). 2012 Oct 1;16(5):315-329. doi: 10.1684/vir.2012.0462. Virologie (Montrouge). 2012. PMID: 33065915 English.

2

[Hepatitis C virus and neutralizing antibodies].

Fauvelle C, Heydmann L, Zeisel MB, Baumert TF, Stoll-Keller F, Fafi-Kremer S. Fauvelle C, et al. Virologie (Montrouge). 2011 Oct 1;15(5):326-336. doi: 10.1684/15-5.2011.17803. Virologie (Montrouge). 2011. PMID: 36151691 French.

3

Neutralizing antibodies and pathogenesis of hepatitis C virus infection.

Fafi-Kremer S, Fauvelle C, Felmlee DJ, Zeisel MB, Lepiller Q, Fofana I, Heydmann L, Stoll-Keller F, Baumert TF. Fafi-Kremer S, et al. Viruses. 2012 Oct 9;4(10):2016-30. doi: 10.3390/v4102016. Viruses. 2012. PMID: 23202451 Free PMC article. Review.

4

Hepatitis C virus vaccines--progress and perspectives.

Fauvelle C, Lepiller Q, Felmlee DJ, Fofana I, Habersetzer F, Stoll-Keller F, Baumert TF, Fafi-Kremer S. Fauvelle C, et al. Microb Pathog. 2013 May;58:66-72. doi: 10.1016/j.micpath.2013.02.005. Epub 2013 Mar 7. Microb Pathog. 2013. PMID: 23499591 Review.

5

45 years after the discovery of human polyomaviruses BK and JC: Time to speed up the understanding of associated diseases and treatment approaches.

Barth H, Solis M, Lepiller Q, Sueur C, Soulier E, Caillard S, Stoll-Keller F, Fafi-Kremer S. Barth H, et al. Among authors: stoll keller f. Crit Rev Microbiol. 2017 Mar;43(2):178-195. doi: 10.1080/1040841X.2016.1189873. Epub 2016 Nov 1. Crit Rev Microbiol. 2017. PMID: 27800693 Review.

6

Problem-based learning in laboratory medicine resident education: a satisfaction survey.

Lepiller Q, Solis M, Velay A, Gantner P, Sueur C, Stoll-Keller F, Barth H, Fafi-Kremer S. Lepiller Q, et al. Among authors: stoll keller f. Ann Biol Clin (Paris). 2017 Apr 1;75(2):181-192. doi: 10.1684/abc.2017.1236. Ann Biol Clin (Paris). 2017. PMID: 28377331 Free article. English.

7

High incidence but low burden of coronaviruses and preferential associations between respiratory viruses.

Lepiller Q, Barth H, Lefebvre F, Herbrecht R, Lutz P, Kessler R, Fafi-Kremer S, Stoll-Keller F. Lepiller Q, et al. J Clin Microbiol. 2013 Sep;51(9):3039-46. doi: 10.1128/JCM.01078-13. Epub 2013 Jul 12. J Clin Microbiol. 2013. PMID: 23850954 Free PMC article.

8

Challenges for HCV vaccine development in HIV-HCV coinfection.

Lambotin M, Barth H, Moog C, Habersetzer F, Baumert TF, Stoll-Keller F, Fafi-Kremer S. Lambotin M, et al. Expert Rev Vaccines. 2012 Jul;11(7):791-804. doi: 10.1586/erv.12.52. Expert Rev Vaccines. 2012. PMID: 22913257 Review.

9

Development of hepatitis C virus vaccines: challenges and progress.

Stoll-Keller F, Barth H, Fafi-Kremer S, Zeisel MB, Baumert TF. Stoll-Keller F, et al. Expert Rev Vaccines. 2009 Mar;8(3):333-45. doi: 10.1586/14760584.8.3.333. Expert Rev Vaccines. 2009. PMID: 19249975 Free PMC article. Review.

10

Toward standardization of BK virus monitoring: evaluation of the BK virus R-gene kit for quantification of BK viral load in urine, whole-blood, and plasma specimens.

Sueur C, Solis M, Meddeb M, Soulier E, Domingo-Calap P, Lepiller Q, Freitag R, Bahram S, Caillard S, Barth H, Stoll-Keller F, Fafi-Kremer S. Sueur C, et al. J Clin Microbiol. 2014 Dec;52(12):4298-304. doi: 10.1128/JCM.02031-14. Epub 2014 Oct 8. J Clin Microbiol. 2014. PMID: 25297334 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

104 results

Search Page